SPANU, DARIO
 Distribuzione geografica
Continente #
EU - Europa 4.692
NA - Nord America 250
AS - Asia 43
OC - Oceania 2
Totale 4.987
Nazione #
IT - Italia 4.592
US - Stati Uniti d'America 245
SE - Svezia 45
IN - India 16
NL - Olanda 13
FI - Finlandia 8
GB - Regno Unito 8
CN - Cina 7
BE - Belgio 6
FR - Francia 6
CA - Canada 4
DE - Germania 4
IE - Irlanda 4
SG - Singapore 4
TH - Thailandia 4
VN - Vietnam 4
GR - Grecia 3
HK - Hong Kong 3
IR - Iran 3
AT - Austria 2
AU - Australia 2
ES - Italia 1
IL - Israele 1
TR - Turchia 1
TT - Trinidad e Tobago 1
Totale 4.987
Città #
Cagliari 4.544
Chandler 45
Nyköping 41
Fairfield 33
Ashburn 17
New York 17
Rome 15
Boardman 12
Seattle 12
Amsterdam 11
Houston 11
Pune 11
San Diego 9
Helsinki 8
Wilmington 8
Woodbridge 7
Boston 6
Cambridge 6
Menlo Park 5
Dong Ket 4
La Maddalena 4
Paris 4
Toronto 4
Islington 3
Peristeri 3
Sassari 3
Brussels 2
Delhi 2
Don Mueang 2
Dublin 2
Enna 2
Godo 2
Hefei 2
Leuven 2
Livorno 2
Molenbeek-Saint-Jean 2
Naples 2
Romainville 2
San Francisco 2
Sydney 2
Vienna 2
Xian 2
Alexandria 1
Amgaon 1
Ankara 1
Bilbao 1
Chandigarh 1
Exeter 1
Frankfurt am Main 1
Frattamaggiore 1
Gela 1
Heidelberg 1
Hounslow 1
Jacksonville 1
Miami Beach 1
Milan 1
Naaldwijk 1
Nanjing 1
New Bedfont 1
Olbia 1
Port-of-spain 1
Pozzuoli 1
Rockville 1
Sambuca di Sicilia 1
San Mateo 1
Shanghai 1
Shenzhen 1
South Deerfield 1
Stockholm 1
Tabriz 1
Washington 1
Totale 4.904
Nome #
Molecular-biology-driven treatment for metastatic colorectal cancer 1.988
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast? 470
Molecular-driven treatment for biliary tract cancer: the promising turning point 378
How to improve metastatic pancreatic ductal adenocarcinoma patients' selection: Between clinical trials and the real-world 377
Uncovering key targets of success for immunotherapy in pancreatic cancer 313
CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors 296
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients 255
BRCA-mutant pancreatic ductal adenocarcinoma 243
Neoadjuvant chemo-radiotherapy response in patients affected by mismatch repair deficient (dMMR) locally advanced rectal cancer 173
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment 171
Circulating tumour DNA in gastrointestinal cancer in clinical practice: Just a dream or maybe not? 169
Mismatch repair proteins (MMR) expression as predictive factor in locally advanced rectal cancer 86
Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment 58
null 47
Totale 5.024
Categoria #
all - tutte 7.701
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.701


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021959 0 0 1 330 197 120 40 64 35 70 49 53
2021/2022892 53 48 3 25 40 78 38 73 63 79 143 249
2022/20232.567 188 345 306 175 170 191 126 215 194 321 206 130
2023/2024606 95 67 76 119 190 59 0 0 0 0 0 0
Totale 5.024